Showing 1–16 of 25 results
-
Asthma Study
Asthma is a chronic condition that inflames and narrows the airways, causing difficulty breathing. Symptoms include coughing, wheezing, shortness of breath, and chest tightness.
Read more
Criteria & Qualifications: • Must be 12 years or older.
• Must have an Asthma diagnosis.
• Must be able to provide medical records.
Compensation:
Up to $2,000 -
Atopic Dermatitis Study
This clinical trial is being conducted to evaluate biomarkers of Atopic Dermatitis in pediatric patients whose disease is not adequately controlled with topical prescription therapies or when those therapies are not medically advisable. Criteria & Qualifications: • Males and Females in good general health
Read more
• Patients with moderate to severe AD whose disease is not adequately controlled with topical therapies
• Must be 0 years to 11 years old
Compensation: Contact us for more information -
Chronic Pancreatitis Study
This clinical trial is being conducted to gather real-world evidence on the experiences of people with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP), to identify the critical factors influencing treatment choices, quality of life, and healthcare utilization outcomes. The goal is to understand the unmet needs and therapeutic burden and improve outcomes by identifying areas for improvement in standard of care. Criteria & Qualifications: • Males and Females in good general health • Diagnosis of chronic pancreatitis or recurrent acute pancreatitis • Is at least 18 years of age or older Compensation: Contact us for more information
Read more -
COVID-19
Test if the drug is safe and effective for the treatment of coronavirus disease 2019 (COVID-19) in participants who have a standard risk of developing severe illness.
Read more
Criteria & Qualifications: • Between 12- 64 years old.
• Infected with COVID-19 within the last 3 days.
Compensation: Up to $1600 -
COVID-19 Study
Interested in our COVID-19 study? We're testing treatments for non-hospitalized patients. You'll get treatment and safety checks. Follow-ups last weeks to months. Help us fight COVID-19!
Read more
Criteria & Qualifications: • COVID-19 positive in the last 10 days.
• Experienced COVID-19 symptoms within 7 days, like fever, cough, trouble breathing, sore throat, body pain, tiredness, headache, stuffy nose, loss of taste/smell, stomach issues, or high temperature.
• Had one or more symptoms in the last 24 hours.
Compensation: Contact Us for more information -
Crohn’s Disease Study
Crohn’s disease is a chronic inflammatory condition that affects the digestive tract. This clinical trial is being conducted to evaluate the efficacy and safety of guselkumab & golimumab in participants with Crohn’s disease.
Read more
Criteria & Qualifications: • Is at least 18 years of age or older.
• Diagnosis of Crohn's disease (CD) for at least 3 months.
• Is willing to provide medical records.
Compensation:
Contact us for more information -
Crohn’s Disease Study
We're offering a study to test a new treatment for severe Crohn's Disease, especially for those who didn't benefit from common treatments. Participants will be divided into groups; some will receive the actual treatment, others a placebo. Those showing significant improvement in the early phase will continue to the next part of the study. Join us to help advance Crohn's Disease research!
Read more
Criteria & Qualifications: • Is at least 18 years of age or older
Compensation: Contact us for more information -
Device Study
Coming Soon! Introducing our multi-target Rapid Antigen Test, designed to detect the presence of specific viral antigens associated with COVID-19, Flu A, Flu B, and RSV (Respiratory Syncytial Virus). This streamlined test offers the unique advantage of identifying multiple respiratory pathogens simultaneously, enabling timely diagnosis and management of infections.
Read more
Criteria & Qualifications: • Individuals should be above 18 years of age.
• Those showing symptoms of respiratory infections or having had contact with confirmed cases.
Compensation: Contact us for more information -
EBV Study
This clinical trial is being conducted to evaluate an investigational vaccine for the prevention of Epstein-Barr Virus (EBV). EBV infection can lead to infectious mononucleosis (also known as “mono”), which is characterized by symptoms such as extreme fatigue, sore throat, swollen glands, and fever.
Read more
Criteria & Qualifications:
• Must be between the age of 12- 17
• Males and Females in good general health
Compensation: Up to $2,600 -
Eosinophilic Asthma
Coming Soon! We're checking if switching treatments for people with severe eosinophilic asthma works as well as their current medication. Everyone taking part will continue with their usual asthma care. Join us to help advance eosinophilic asthma treatment!
Read more
Criteria & Qualifications: • More than 12 Years and older.
Compensation: Contact us for more information -
Erosive Esophagitis
We invite you to participate in a study evaluating the safety and effectiveness of a new oral treatment compared to a standard control in treating and maintaining healed EE.
Read more
Criteria & Qualifications: • Is at least 18 years of age or older.
• Experience heartburn and/or regurgitation consistent with Erosive Esophagitis (EE).
Compensation: Up to $1700 -
Inflammatory Bowel Disease (IBD)
We invite you to participate in a study to assess the safety and effectiveness of a new oral medication, compared to a standard control, for treating and maintaining stable conditions in individuals with Inflammatory Bowel Disease (IBD).
Read more
Criteria & Qualifications: • Must be 18 years of age or older.
• Diagnosis of Crohn’s disease or Ulcerative Colitis.
Compensation: Contact us for more information -
Kidney Disease
This study checks a new treatment for severe kidney disease with hormone issues. It has two parts: one with real and fake treatments, and one where all get the real treatment. Doctors will test the results.
Read more
Criteria & Qualifications: • Age 18-80.
• On hemodialysis 3x a week for 3+ months.
Compensation: Contact us for more information -
Meningitis Study
This clinical trial is being conducted to evaluate the safety and immunogenicity of a Meningococcal vaccine in infants 6 weeks through 12 weeks of age, when administered concomitantly with Pneumococcal conjugate vaccine and other recommended routine infant vaccines (RIV).
Read more
Criteria & Qualifications:
• Males and Females in good general health
• Must be 6 weeks to 12 weeks old
Compensation: Contact us for more information -
NASH
Coming Soon! NASH is a quiet liver disease that often shows no symptoms until it's severe. It starts with extra liver fat and can lead to serious liver damage. Early action is key to preventing it from getting worse.
Read more
Criteria & Qualifications: • Must be between 18 and 75 years old, and can be either a man or a woman.
• Must be obese with a BMI of 27 or higher.
• Diagnosed with Fatty Liver Disease.
Compensation: Contact us for more information -
NASH Study
Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH.
Read more
Criteria & Qualifications: • Is at least 18 years of age or older.
• Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH).
• Must be weight stable for 6 months.
Compensation:
Up to $3,000.
